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While adipogenesis is known to be controlled by
a complex network of transcription factors, less is
known about the transcriptional cascade that initi-
ates this process. We report here the characteriza-
tion of Kru¨ppel-like factor 4 (KLF4) as an essential
early regulator of adipogenesis. Klf4 is expressed in
3T3-L1 cells within 30 min after exposure to a stan-
dard adipogenic cocktail of insulin, glucocorticoids,
and IBMX. Knockdownof KLF4 inhibits adipogenesis
and downregulates C/EBPb levels. KLF4 binds di-
rectly to the C/EBPb (Cebpb) promoter as shown
by chromatin immunoprecipitation and gel shift as-
says and, together with Krox20, cooperatively trans-
activates a C/EBPb reporter. C/EBPb knockdown in-
creases levels of KLF4 and Krox20, suggesting that
C/EBPb normally suppresses Krox20 and KLF4 ex-
pression via a tightly controlled negative feedback
loop. KLF4 is specifically induced in response to
cAMP, which by itself can partially activate adipo-
genesis. These data suggest that KLF4 functions
as an immediate early regulator of adipogenesis to
induce C/EBPb.
INTRODUCTION
Obesity, defined as an excess amount of body fat relative to lean
bodymass, is amajor health concern in the United States and an
increasing problem in the developing world (Friedman, 2004).
A fuller understanding of the molecular processes governing
adipose tissue formation is of basic and potentially clinical
importance.
Two decades of research have revealed that adipogenesis
is controlled by a complex network of transcription factors,
including numerous transcriptional activators, coactivators,
and repressors (Farmer, 2006). When confluent 3T3-L1 and
3T3-F442A cell lines are exposed to a cocktail of hormonal stim-
ulants, these cell lines accumulate lipid and develop the charac-
teristic morphology of mature adipocytes (Green and Meuth,
1975). The earliest inductive event in this process is transcrip-
tional activation of two of the C/EBP family of transcription
factors, C/EBPb and C/EBPd, which then stimulate expression
of PPARg, the major late transcription factor (Cao et al., 1991;
Lane et al., 1999; Wu et al., 1995; Yeh et al., 1995). PPARg isnecessary and sufficient for adipocyte differentiation (Tontonoz
et al., 1994). However, less is known about what controls
C/EBP gene expression. Identification of the factors that regu-
late these important early genes in preadipocytes would provide
additional insight into the mechanisms regulating the initiation of
fat cell differentiation.
In an earlier paper, we showed that Krox20 is expressed early
in adipogenesis and can transactivate C/EBPb (Chen et al.,
2005). However, we were unable to show direct binding of
Krox20 to the C/EBPb (Cebpb) promoter despite the fact that it
potently transactivates a luciferase reporter driven by an element
between1.45 kb to1.1 kb upstream of the C/EBPb transcrip-
tion initiation site. These findings suggested that Krox20 might
interact with another factor to transactivate the C/EBPb pro-
moter. We considered the possibility that this additional factor
might be included in a panel of transcription factors that are ex-
pressed at a much higher level in white adipose tissue in vivo
than in 3T3-L1 cells in vitro (Soukas et al., 2001). It was this
same panel that led to the identification of Krox20.
One of the transcription factors induced in vivo is Kru¨ppel-
like factor 4 (KLF4; also known as GKLF/ZIF), a member of
a large family of zinc-finger proteins that is known to play im-
portant roles in differentiation and proliferation (Ghaleb et al.,
2005). Several other KLFs have previously been implicated in
the regulation of adipogenesis. KLF6 and KLF15 have both
been shown to promote adipogenesis, and KLF15 also upregu-
lates GLUT4 expression (Li et al., 2005; Mori et al., 2005). In
addition, another KLF factor, KLF5, is necessary for adipocyte
differentiation and acts by transactivating the PPARg (Pparg)
promoter (Oishi et al., 2005). All of these KLF factors are
thought to function through different coactivators or repressors
(Farmer, 2006).
However, a role of KLF4 in adipogenesis has not been previ-
ously demonstrated. KLF4 is highly expressed in differentiated,
postmitotic cells of the skin and the gastrointestinal tract, and
it has been suggested to play a variety of roles as a differentia-
tion/proliferation switch and regulator of the cell cycle (Garrett-
Sinha et al., 1996; Shields et al., 1996; Takahashi and Yamanaka,
2006; Yoon et al., 2003).Klf4 knockout mice die12 hr after birth
due to defects in skin development with a failure of normal base-
ment membrane formation (Segre et al., 1999). In thesemice, the
skin’s fat layer is disrupted, causing the loss of skin barrier func-
tion and rapid loss of body fluids (Segre et al., 1999). We thus
considered the possibility that KLF4 might play a role in regulat-
ing the development of adipose tissue and tested this possibility
by studying the functional role of KLF4 during the differentiation
of 3T3-L1 adipocytes.Cell Metabolism 7, 339–347, April 2008 ª2008 Elsevier Inc. 339
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KLF4 Is an Early and Obligate 3T3-L1
Differentiation Factor
We showed previously that KLF4 is highly enriched in white ad-
ipose tissue compared to fully differentiated 3T3-L1 adipocytes
in vitro (Soukas et al., 2001). Because adipose tissue in vivo in-
cludes stromal elements and preadipocytes, this raised the pos-
sibility that KLF4 might be expressed in the stromal/preadipo-
cyte fraction and play a role in the early stages of adipocyte
differentiation. To assess this, we assayed Klf4 gene expression
at numerous time points early in 3T3-L1 differentiation induced
using the standard IBMX, dexamethasone, and insulin cocktail.
Quantitative RT-PCR revealed that KLF4 mRNA appeared
30 min postinduction and peaked at 2 hr postinduction. Protein
levels for KLF4 were consistent with the mRNA levels
(Figure 1A). This result shows that KLF4 is expressed very early
in the course of 3T3-L1 differentiation with a pattern similar to
that of other previously described early transcription factors, in-
cluding Krox20, C/EBPb, and C/EBPd (see Figure S1 available
online). These same factors were also enriched in the stromal/
preadipocyte fraction of the adipose tissue compared to the
adipocyte fraction (Figure 1B).
The role of KLF4 in adipogenesis was tested using retroviruses
carrying small interfering RNA (siRNA) for KLF4 to knock down its
expression. Two independent hairpin siRNA sequences for KLF4
(cloned into the pSIREN-RetroQ-puro retroviral plasmid) were
effective in knocking down Klf4 expression (Figure 1C). 3T3-L1
cells were infected with these two KLF4 siRNA-containing retro-
viruses along with a control hairpin. After selection with puromy-
cin, we established stable cell lines with constitutive siRNA ex-
pression. Note that these cell lines were a mixture of all cells
expressing the selectable marker and were not clonal. These
stable cell lines were cultured to confluence and differentiated
using the standard induction cocktail for 8 days. Oil red O stain-
ing revealed that both KLF4 knockdown cell lines accumulated
significantly less lipid than the control cell line (Figure 1C). RNA
levels of adipogenic regulators such as adipsin, aP2, and PPARg
were also reduced consistent with the oil red O staining. In addi-
tion, early C/EBPb expression was also reduced in the KLF4
knockdown cell lines compared to control cells (Figure 1D).
These results suggest that Klf4 is necessary for normal differen-
tiation of 3T3-L1 cells and acts upstream of C/EBPb and PPARg.
Of note, however, the reduction of PPARg gene expression was
not proportional to the decrease in adipogenesis, suggesting
that KLF4 might partially promote the differentiation of adipo-
cytes independently of PPARg.
KLF4 Transactivates C/EBPb
The data shown above suggested that KLF4 might regulate
C/EBPb transcription. To test this hypothesis, a plasmid ex-
pressing hemagglutinin (HA)-tagged KLF4 protein (KLF4-HA) or
a control plasmid was cotransfected into 293T cells with a
C/EBPb promoter-luciferase reporter plasmid (B3K), which con-
tains 3 kb of the C/EBPb promoter. These data showed that
KLF4 transactivated the C/EBPb promoter (B3K) by 10 fold in
a dose-dependent manner (Figure S2).
To further narrow down the region or regions responsible for
the transactivation of Klf4, we generated a series of 50 deletions340 Cell Metabolism 7, 339–347, April 2008 ª2008 Elsevier Inc.of the C/EBPb promoter and analyzed the induction in response
to KLF4. Transactivation by KLF4 dropped by more than 5-fold
when a region from1.45 kb to1.1 kb was deleted (Figure 2A).
Deletion of sequences from the3 kb to1.5 kb region resulted
in a further 2-fold decrease in the activation.
To assess whether KLF4 directly activates the C/EBPb gene,
we next assayed the binding of KLF4 to the endogenous
C/EBPb promoter in 3T3-L1 cells using chromatin immunopre-
cipitation (ChIP) assays. 3T3-L1 cells were differentiated for
2.5 hr, at which time DNA-protein complexes were crosslinked
and ChIP assay was performed using an anti-KLF4 antibody or
rabbit IgG as a control. ChIP using the anti-KLF4 antibody
caused a significant enrichment of the C/EBPb promoter se-
quence, indicating that the KLF4 transcription factor is directly
bound to the C/EBPb promoter (Figure 2B). Further characteriza-
tion of the region between 1.45 kb to 1.1 kb of the C/EBPb
promoter was performed using gel shift assays with fragments
of the promoter and bacterially expressed KLF4. Seven 55 bp oli-
gos spanning the 1.45 kb to 1.1 kb region were incubated
with recombinant GST-KLF4 protein. GST-KLF4 shifted three
of these oligos, and this was correlated with the results of a co-
transfection of KLF4 with a series of C/EBPb promoter deletions
between 1.45 kb to –1.1 kb (Figure S3) Taken together, these
findings suggest that KLF4 transactivates the C/EBPb gene by
binding directly to several sites on the1.45 kb to1.1 kb region
of the promoter. However, the sequences of these oligonucleo-
tides were different, and DNase footprinting failed to reveal
a clear consensus sequence (data not shown). This suggests
that the KLF4 binding site may be highly degenerate. Nonethe-
less, a cross-species comparison of the C/EBPb promoter fur-
ther indicated that the 1.45 kb to 1.1 kb region is the only re-
gion that is significantly conserved among mammals (Figure S4).
KLF4 and Krox20 Bind Together to Transactivate
C/EBPb
It was previously reported that Krox20 can also transactivate the
C/EBPb promoter via sequences between 1.45 kb to 1.1 kb,
as reported above for Klf4 (Chen et al., 2005). The fact that KLF4
and Krox20 also have similar expression kinetics led us to exam-
ine whether the ability of these transcription factors to activate
the C/EBPb promoter is synergistic. Plasmids directing the ex-
pression of Krox20 and KLF4 were cotransfected into 293T cells
using the same C/EBPb promoter-luciferase reporter plasmid.
Transfection of KLF4 or Krox20 alone led to a 6-fold or 4-fold
induction, respectively, while simultaneous transfection of both
plasmids increased luciferase activity 10-fold (Figure 2C).
Since Krox20 (Chen et al., 2005) and KLF4 bind to the same
region and can both activate transcription of C/EBPb, we consid-
ered the possibility that these proteins might interact. FLAG-
tagged KLF4 and HA-tagged Krox20were ectopically expressed
in 293T cells for 2 days. The lysate was immunoprecipitated us-
ing anti-FLAG M2 agarose beads, washed extensively with
BA300 (300 mM NaCl), and immunoblotted using an anti-HA an-
tibody. In this assay, immunoprecipitation of KLF4 using an anti-
FLAG antibody pulled down Krox20 (Figure 2D). Consistent with
this result, purified GST-KLF4 pulled down in vitro-translated
Krox20 in in vitro pull-down assays (Figure 2E). In addition, stud-
ies using a standard mammalian two-hybrid assay provided
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Role of KLF4 in AdipogenesisFigure 1. Expression and Function of KLF4
(A) Expression of KLF4 during differentiation of 3T3-L1 cells was analyzed using TaqMan RT-PCR and western blotting. Cells were harvested at the indicated
times. Cyclophilin was used as an internal control for TaqMan analysis.
(B) Expression of early genes in adipocyte fraction and stromovascular fraction. TaqManRT-PCRwas performed in the adipocyte and stromovascular fractions of
adipose tissue disintegrated by collagenase. Leptin levels (enriched in the adipose fraction) were checked as a control of the preparation. Error bars indicate SEM.
(C) KLF4 knockdown impairs adipogenesis. 3T3-L1 cells were infected with pSIREN-RetroQ-derived retroviruses carrying either siRNA oligos for KLF4 or control
oligos, selected for puromycin resistance, expanded as a mixed population, and induced to differentiate using MDI cocktail. Upper panel: efficiency of the two
knockdown plasmids against KLF4 by TaqMan assay. Lower panel: oil red O staining of KLF4 knockdown and control hairpin cell lines at day 8.
(D) Expression levels of C/EBPb and the fat markers PPARg, adipsin, and aP2 in control and KLF4 knockdown 3T3-L1 cell lines at different time points during
differentiation.functional evidence that Krox20 and KLF4 can bind to one
another and activate gene expression (Figure S5).
Krox20 and C/EBPb Partially Overcome
KLF4 Knockdown
The data suggested that KLF4 acts upstream of C/EBPb. If this is
true, we would expect that overexpression of C/EBPb or Krox20
should bypass the effect of KLF4 knockdown. To test this, 3T3-
L1 cells were infected with retroviruses carrying KLF4 siRNAs
and either Krox20-HA or C/EBPb. These data confirmed thatthe negative effect of KLF4 knockdown on adipogenesis
can be ameliorated by the overexpression of either Krox20 or
C/EBPb as assessed by oil red O staining and measuring the
level of expression of aP2, PPARg, and adipsin (Figures 3A
and 3B).
KLF4 Expression Is IBMX but Not Dexamethasone
or Insulin Dependent
Our data show that KLF4 and Krox20 cooperate to activate
C/EBPb transcription and establish them as among the earliest,Cell Metabolism 7, 339–347, April 2008 ª2008 Elsevier Inc. 341
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is true, both factors might be expected to respond directly to
one of the components of the adipogenic cocktail and not to
the others. To test this, confluent 3T3-L1 cells were exposed in-
dividually to each of the three components of the induction cock-
tail: insulin, dexamethasone (DEX), and the phosphodiesterase
inhibitor IBMX. Insulin and DEX concentrations did not affect
KLF4 levels at 2 hr postinduction, the time at which KLF4 is max-
imally induced in response to the three-component cocktail. On
the other hand, IBMX increased KLF4 levels 4- to 5-fold
(Figure 3C), and increasing concentrations of IBMX proportion-
ally increased C/EBPb and Klf4 gene expression (Figure 3C;
Figure S6).
Figure 2. KLF4 Transactivates the C/EBPb
Promoter by Binding to a Conserved 1.45–
1.1 kb Region
(A) A deletion series derived from a luciferase re-
porterconstruct (B3K) carrying the3kbpromoter re-
gionofC/EBPb (Cebpb) was cotransfectedwith250
ngofpMSCV-KLF4andpRL-TK (renilla).Results are
expressed as firefly luciferase activity normalized to
renilla luciferase activity. Error bars indicate SEM.
(B) Chromatin immunoprecipitation (ChIP) analysis
of KLF4 binding to the target region on the C/EBPb
promoter. 3T3-L1 cells were fixed 2.5 hr postinduc-
tion,andchromatinsamplesweresubjected toChIP
assays using a KLF4 antibody or normal rabbit
IgG as a control. An upstream region (2.5 kb) in
the C/EBPb promoter was checked as a negative
control.
(C)KLF4andKrox20cooperatively transactivate the
C/EBPb promoter. KLF4 and Krox20 expression
plasmids were cotransfectedwith the C/EBPb lucif-
erase reporterconstruct.Anadditiveeffect for trans-
activating theC/EBPbpromoterwasdemonstrated.
Error bars indicate SEM.
(D) Coimmunoprecipitation of KLF4 with Krox20.
FLAG-KLF4 and Krox20-HA were cotransfected
into 293T cells. After 2 days, cells were lysed and
coimmunoprecipitatedusingananti-FLAGantibody
and immunoblotted against HA. The data show the
specific binding of KLF4 to Krox20.
(E) GST pull-down assays. Krox20 and luciferase
plasmids were in vitro translated in the presence of
35S, mixed with purified GST-KLF4, and pulled
down by GST beads. Krox20, but not luciferase,
was pulled down by GST-KLF4.
To further assess the effect of IBMX on
Klf4, we transfected 293T cells with a lu-
ciferase reporter driven by the 2 kb Klf4
promoter. When the transfected cells
were exposed to IBMX, a 3- to 4-fold in-
crease in luciferase activity was observed
(Figure 3D).
KLF4 and Krox20 Are Regulated
through a Negative Feedback Loop
KLF4, Krox20, and C/EBPb compose
a network of transcription factors that
play a key role in orchestrating the early
events of adipogenesis. We explored the interaction among
these factors by analyzing their expression in cells in which
only one of these transcription factors was knocked down by
stable expression of the corresponding siRNA. The C/EBPb
knockdown cell lines showed a robust 2-fold increase in
Krox20 and KLF4 expression levels at 2 hr postinduction, sug-
gesting that C/EBPb expression normally inhibits its upstream
activators via a negative feedback mechanism. These data pro-
vide further evidence that C/EBPb is a downstream target of
KLF4 and Krox20 (Figure 4A).
Consistent with this hypothesis, a 3T3-L1 cell line overex-
pressing C/EBPb showed a robust early decrease in KLF4,
and to a lesser extent Krox20, expression levels (Figure 4B). A342 Cell Metabolism 7, 339–347, April 2008 ª2008 Elsevier Inc.
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Role of KLF4 in AdipogenesisFigure 3. Krox20 and C/EBPb Overexpression Partially Overcomes Knockdown of KLF4
3T3-L1 cells were coinfected with pMSCVhyg-derived retroviruses carrying either Krox20-HA/C/EBPb or control insert and pSIREN-RetroQ-derived retroviruses
carrying either siRNA oligos for KLF4 or control oligos, selected for hygromycin and puromycin resistance, and induced to differentiate until day 7.
(A and B) Overexpression of Krox20 (A) or C/EBPb (B) overcomes knockdown of KLF4. Upper panels show oil red O staining; lower panels show TaqMan analysis
of aP2, PPARg, and adipsin.
(C and D) KLF4 expression is dependent on IBMX, but not on dexamethasone or insulin.
(C) Individual components of the induction cocktail (IBMX, dexamethasone [DEX], and insulin) were added to confluent 3T3-L1 cells alone or in combination. Cells
were harvested 2 hr posttreatment for TaqMan analysis of KLF4. Left panel: effect of each component on KLF4 expression. Right panel: dose-dependent induc-
tion of KLF4. Confluent 3T3-L1 cells were treated with increasing amounts of IBMX (0 to 0.5 mM). Cells were harvested 2 hr postinduction for TaqMan analysis.
Error bars indicate SEM.
(D) IBMX can transactivate theC/EBPbpromoter in 293T cells in vitro. 293T cells were transfectedwith aKfl4-luciferase reporter plasmid carrying 2 kb upstreamof
the Kfl4 promoter. After 16 hr, the cells were treated with either DMSO or 0.5 mM IBMX for 8 hr and then harvested for luciferase assays. Error bars indicate SEM.negative effect of C/EBPb on Klf4 expression was also seen
using the KLF4-luciferase reporter. Coexpression of the KLF4-
luciferase reporter with C/EBPb in 293T cells reduced KLF4
expression by as much as 30% and was dose dependent.
This inhibition was even more robust, 70%, when these cellswere incubated with IBMX (Figure 4C). These results suggest
a potential negative feedback mechanism whereby C/EBPb ac-
tively downregulates its upstream regulators and provide further
support for the possibility that KLF4 and Krox20 act upstream
of C/EBPb.Cell Metabolism 7, 339–347, April 2008 ª2008 Elsevier Inc. 343
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Role of KLF4 in AdipogenesisFigure 4. KLF4 and Krox20 Are Regulated by C/EBPb through a Negative Feedback Loop
3T3-L1 cells were infected with retroviruses expressing C/EBPb knockdown or overexpression constructs. Cells were selected and differentiated, and the effect
of C/EBPb expression on KLF4 was observed.
(A) KLF4 and Krox20 levels are upregulated in C/EBPb knockdown 3T3-L1 cells.
(B) KLF4 and Krox20 levels are downregulated in 3T3-L1 cells overexpressing C/EBPb.
(C) Kfl4 transcription is inhibited by C/EBPb. 293T cells were cotransfected with increasing amounts of C/EBPb plasmid along with a luciferase reporter plasmid
carrying the 2 kbKfl4 promoter. After 16 hr, the cells were treated with DMSO or 0.5mM IBMX for 8 hr and then harvested for luciferase assays. Error bars indicate
SEM.Overall, these data indicate that the level of expression of
KLF4 is tightly controlled, a finding that is consistent with the ob-
servation that overexpression of KLF4 leads to cell-cycle arrest
in preadipocytes (and other cell types), further suggesting that
KLF4 must be expressed at tightly regulated levels in a narrow
window during adipogenesis.
DISCUSSION
Adipogenesis is controlled by a cascade of transcription factors
that act to induce the expression of gene products necessary for
the acquisition of the characteristic morphology and specialized
functions of adipocytes (Farmer, 2006). C/EBPb has previously
been shown to be among the first transcription factors activated
during adipogenesis, and it is considered to be one of the initia-
tors of a transcriptional cascade, which in turn activates C/EBPa
and PPARg (Rosen et al., 2002). These latter genes then activate
the genes that mark the fully differentiated adipocyte phenotype.
However, the upstream factors regulating C/EBPb expression
have not been characterized. We have previously reported that
Krox20 can partially activate C/EBPb (Chen et al., 2005). Here
we report that KLF4, another transcription factor expressed early
during adipogenesis, can also transactivate C/EBPb and that the344 Cell Metabolism 7, 339–347, April 2008 ª2008 Elsevier Inc.combination of KLF4 and Krox20 can markedly induce C/EBPb
expression.
Klf4 gene expression is induced early during adipogenesis in
response to IBMX, one of the components of the standard in-
duction cocktail. KLF4 knockdown cell lines showed a marked
decrease in adipogenesis as assessed using oil red O and re-
duced expression of differentiated fat markers such as aP2,
adipsin, and PPARg. However, the decrease in PPARg expres-
sion seems to be less prominent than for the other two
markers, suggesting that KLF4 might have PPARg2-indepen-
dent effects. KLF4 knockdown cells also showed reduced ex-
pression of C/EBPb, adding functional evidence to support the
conclusion that KLF4 is an upstream factor of C/EBPb in the
transcriptional network controlling adipogenesis. Consistent
with this, KLF4 is able to transactivate a luciferase reporter
driven by the 3 kb C/EBPb promoter in a dose-dependent
manner, and a deletion series further localized the critical
region to between the 1438 and 1134 base pairs. ChIP
assays and gel shift assays confirmed the binding of KLF4 to
the C/EBPb promoter at this conserved critical region. KLF4
seems to bind several sites along this region, and we failed
to find a clear consensus sequence for KLF4 binding as
assessed by footprinting studies (data not shown). However,
Cell Metabolism
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suggests that these promoter sequences are functionally
important.
Krox20 has previously been shown to activate the C/EBPb
promoter in the same promoter region (Chen et al., 2005).
Krox20 transactivation is additive with KLF4, suggesting that
both factors cooperate to activate C/EBPb expression in adipo-
genesis. In addition, overexpression of either Krox20 or C/EBPb
seems to bypass the KLF4 knockdown phenotype, further sup-
porting a role of Krox20 and KLF4 in activating C/EBPb. We
have also shown that, in cooperation with p300, these two fac-
tors potently transactivate the C/EBPb promoter (Figure S9).
p300 has previously been shown to interact directly with KLF4
by pull-down assays (Feinberg et al., 2005). These data suggest
that p300 might play a role in early phases of adipogenesis via
interactions with Krox20 and KLF4 potentially with other proteins
to form a protein complex that induces C/EBPb and coordinates
some (though not all; see below) of the key early events during
adipogenesis.
Knockdown of C/EBPb increases KLF4 expression, and over-
expression of C/EBPb reduces KLF4 expression. These data
support that C/EBPb is downstream of KLF4 and reduces its ex-
pression by feedback inhibition. The need to downregulate KLF4
is not clear, though it could be related to KLF4’s known effect of
arresting the cell cycle in other cell types in some contexts. Ec-
topic expression of KLF4 results in cell-cycle arrest in several
cell lines, including NIH 3T3 cells, and its transcriptional targets
are involved in differentiation and cell-cycle inhibition (Chen
et al., 2001, 2003; Shields et al., 1996). Consistent with this, we
found that marked overexpression of KLF4 in 3T3-L1 cells also
leads to slow proliferation even before differentiation, and these
cells differentiate extremely poorly (Figure S7). These results
suggest that the levels of KLF4 must be tightly controlled quan-
titatively and/or temporally.
Klf4 is specifically activated by IBMX, an inducer of cAMP, but
not by DEX or insulin, the other two components of the adipo-
genic cocktail. IBMX by itself can partially induce adipocyte dif-
ferentiation in 3T3-L1 cells in vitro, but IBMX treatment does not
fully recapitulate the effects of the entire cocktail (Yeh et al.,
1995). This suggests that other factors activated by DEX and in-
sulin in combination with KLF4 are necessary for the activation of
the fully differentiated adipocyte phenotype. It is not known
whether the failure of IBMX to fully activate adipogenesis is the
result of a failure to fully induce the quantitative expression of
downstream mediators such as C/EBPs or whether additional,
as yet unidentified factors are required. The identification of
these DEX- and insulin-induced target genes would resolve
this issue and advance our understanding of the earliest events
in adipogenesis. It is not known, however, whether KLF induction
by cAMP is a direct effect via protein kinase A (PKA) phosphor-
ylation of CREB-family transcription factors or whether another
mechanism contributes (Reusch et al., 2000; Zhang et al.,
2004). CREB phosphorylation is not effected by KLF4 knock-
down (Figure S8), which suggests either that KLF4 might act
downstream of CREB or that other cAMP-responsive transcrip-
tion factors are involved. Cotransfection of a Klf4 promoter-lucif-
erase reporter construct with CREB in the presence of forskolin
did not show any increase in KLF4 expression (data not shown).
This result suggests either that the responsive element for CREBis not represented in the promoter or that cAMP regulation
of KLF4 expression is mediated by a different transcriptional
activator.
The role of KLF4 in vivo could be further tested in fat-specific
knockouts of Klf4; however, the interpretation of such data could
be complicated by the fact that expression of KLF4 might not be
required at later times in adipogenesis such as when the aP2
promoter is turned on, for example in aP2-Cre or leptin-Cre
mice (unpublished data) (Jones et al., 2005). In other words,
aP2-directed knockout of Klf4 would not be informative if Klf4
is not required for the maintenance of adipose tissue. The low
levels of KLF4 in fully differentiated adipocytes are consistent
with this possibility. Thus, promoters that direct Cre expression
early in adipogenesis—i.e., in preadipocytes—are likely to be re-
quired to assess the inductive role of Klf4 in tissue-specific
knockouts. Because such promoters are not available, the delin-
eation of a role for Klf4 in vivo might require an embryonic stem
cell complementation strategy analogous to that recently devel-
oped for the study of pancreatic development (Stanger et al.,
2007).
In summary, we report the identification of Klf4 as an essential
player in adipocyte differentiation. Our findings place KLF4
among a group of key proadipogenic early transcription factors,
including Krox20 and CREB (Reusch et al., 2000; Zhang et al.,
2004). It seems that there is an earlier transcriptional regulatory
network before C/EBPb expression, at least in vitro. Klf4 is in-
duced by cAMP and in turn controls C/EBPb expression, linking
the hormonal cocktail response to C/EBPb. KLF4 can now be
added to the growing list of KLF-family transcription factors
that have roles as pro- or antiadipogenic mediators. KLF tran-
scription factors act as transcriptional activators or repressors,
depending on their interaction with various coactivators or core-
pressors and the context of the cell. In vivo studies of Klf4 func-
tion will be necessary to evaluate the precise roles of these early
transcription factors in adipogenesis and to determine whether
there is functional redundancy. Since these genes are ex-
pressed very early during differentiation of adipocytes, well be-
fore the differentiated markers typically used to drive Cre ex-
pression in adipocyte-specific knockouts, new in vivo systems




For overexpression studies, KLF4 cDNAwas cloned by RT-PCR, and a HA epi-
tope was added at the C terminus. The KLF4-HA fragment was subsequently
inserted into pMSCVpuro (Clontech). Other pMSCV vectors were used as in
Chen et al. (2005). FLAG-KLF4 was courtesy of D. Boyd. Retroviral infections
and 3T3-L1 differentiations are described in Supplemental Experimental
Procedures.
RT-PCR Analysis
Total RNA was isolated by homogenizing cells in TRIzol reagent (Invitrogen)
and subsequently cleaning up RNA using a QIAGEN RNA prep kit. Real-time
PCR was performed using the TaqMan system (Applied Biosystems) accord-
ing to the manufacturer’s instructions. Oligos were designed using Primer Ex-
press software. Amount of expression was normalized to cyclophilin for cell
culture experiments and to ELK3 for preadipocyte fraction experiments. Se-
quences of TaqMan primers and probes were as described in Chen et al.
(2005) and Supplemental Experimental Procedures.Cell Metabolism 7, 339–347, April 2008 ª2008 Elsevier Inc. 345
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Role of KLF4 in AdipogenesisTransfections, Reporter Assays, and Immunoblotting
The C/EBPb reporter was kindly provided by D. Lane. Deletions were made by
PCR and cloned into pGL3 plasmids. (Primers are listed in Supplemental Ex-
perimental Procedures.) Reporter plasmids along with effector plasmids
were transfected into 293T cells at 80%–90% confluence using FuGENE 6
(Roche). pRL-TK (Promega), which carries renilla luciferase (Promega), was
also cotransfected as an internal control for transfection efficiency. Cells
were harvested after 20–24 hr, and luciferase activity was analyzed using
a Promega dual-luciferase assay kit as recommended by the manufacturer.
Western blotting was performed as described previously (Boyer-Guittaut
et al., 2005).
GST Pull-down and Coimmunoprecipitation
293T cells grown in DMEM supplemented with 10% FBS were transiently
transfected using FuGENE 6 according to the manufacturer’s recommenda-
tions. Transfected cells were harvested in BA300 buffer (BA0 with 300 mM
NaCl) after 36 hr, and lysates were used for coimmunoprecipitation as
described previously (Dou et al., 2005). Klf4 was cloned by PCR from
pMSCVpuro-Klf4 and subsequently inserted into the pGEX-T1 plasmid to ex-
press GST-KLF4 protein. GST-KLF4 protein was isolated as described previ-
ously (Morlon and Sassone-Corsi, 2003). In vitro transcription and translation
of the Krox20 protein were performed using the TNT T7 Quick-Coupled Tran-
scription/Translation Kit (Promega). GST pull-down assay is described in detail
in the Supplemental Experimental Procedures.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and nine
figures and can be found with this article online at http://www.
cellmetabolism.org/cgi/content/full/7/4/339/DC1/.
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